Manufacturer
INSTITUTO BIOLOGICO CONTEMPORANEO S.A.
Contents
Labetalol HCl
Indication
Emergency treatment of hypertension, Hypotensive anaesthesia, Hypertension after myocardial infarction, Hypertension in pregnancy.
Instruction
Administer via IV injection/IV infusion.
Drug interaction
Synergistic hypotensive effect w/ halothane. Increased absolute bioavailability w/ cimetidine. Decreased absolute bioavailability w/ glutethimide. Additive hypotensive effect w/ nitroglycerin. Increased incidence of tremor w/ TCAs. Increased risk of bradycardia and heart block w/ Ca channel blocker (e.g. verapamil, diltiazem).
Malaysia
